Search research articles
Contact Us
Filters
Showing results (11-20 of 154) with videos related to
Page
of 16
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
February 7, 2013
Menopause, estrogens and frailty
Anders Nedergaard, Kim Henriksen, Morten Asser Karsdal, et al.
Calcified Tissue International
|
October 30, 2008
Characterization of the bone phenotype in ClC-7-deficient mice
Anita Vibsig Neutzsky-Wulff, Morten A Karsdal, Kim Henriksen
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
July 30, 2013
Musculoskeletal ageing and primary prevention
Anders Nedergaard, Kim Henriksen, Morten A Karsdal, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 17, 2008
Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality
Morten A Karsdal, Kim Henriksen, Michel Arnold, et al.
Frontiers in Neurology
|
May 15, 2025
Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson's disease
Meryem Benmarce, Kim Henriksen, Morten Karsdal, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
September 22, 2012
Serological muscle loss biomarkers: an overview of current concepts and future possibilities
Anders Nedergaard, Morten A Karsdal, Shu Sun, et al.
European Journal of Pharmacology
|
November 22, 2022
Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin
Simone A Melander, Anna Katri, Morten A Karsdal, et al.
Expert Opinion on Therapeutic Targets
|
May 12, 2015
Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders
Kim Henriksen, Christian Schneider Thudium, Claus Christiansen, et al.
Plos One
|
September 11, 2010
The G215R mutation in the Cl-/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect
Patrick Schulz, Johannes Werner, Tobias Stauber, et al.
Biomedicines
|
October 27, 2022
The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy
Nina Sonne, Anna Thorsø Larsen, Morten Asser Karsdal, et al.
Page
of 16
Search research articles
Search
Showing results (11-20 of 154) with videos related to
Sort By:
Page
of 16
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
February 7, 2013
Menopause, estrogens and frailty
Anders Nedergaard, Kim Henriksen, Morten Asser Karsdal, et al.
Calcified Tissue International
|
October 30, 2008
Characterization of the bone phenotype in ClC-7-deficient mice
Anita Vibsig Neutzsky-Wulff, Morten A Karsdal, Kim Henriksen
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
July 30, 2013
Musculoskeletal ageing and primary prevention
Anders Nedergaard, Kim Henriksen, Morten A Karsdal, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 17, 2008
Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality
Morten A Karsdal, Kim Henriksen, Michel Arnold, et al.
Frontiers in Neurology
|
May 15, 2025
Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson's disease
Meryem Benmarce, Kim Henriksen, Morten Karsdal, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
September 22, 2012
Serological muscle loss biomarkers: an overview of current concepts and future possibilities
Anders Nedergaard, Morten A Karsdal, Shu Sun, et al.
European Journal of Pharmacology
|
November 22, 2022
Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin
Simone A Melander, Anna Katri, Morten A Karsdal, et al.
Expert Opinion on Therapeutic Targets
|
May 12, 2015
Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders
Kim Henriksen, Christian Schneider Thudium, Claus Christiansen, et al.
Plos One
|
September 11, 2010
The G215R mutation in the Cl-/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect
Patrick Schulz, Johannes Werner, Tobias Stauber, et al.
Biomedicines
|
October 27, 2022
The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy
Nina Sonne, Anna Thorsø Larsen, Morten Asser Karsdal, et al.
Page
of 16